The full dataset viewer is not available (click to read why). Only showing a preview of the rows.
Error code: DatasetGenerationCastError
Exception: DatasetGenerationCastError
Message: An error occurred while generating the dataset
All the data files must have the same columns, but at some point there are 25 new columns ({'event_soc', 'event_pt', 'concomitant_medications', 'bun_mg_dl', 'bilirubin_mg_dl', 'ast_u_l', 'receive_date', 'creatinine_mg_dl', 'action_taken', 'event_hlgt', 'event_duration_days', 'route', 'treatment_duration_days', 'event_hlt', 'weight_kg', 'dose_frequency', 'indication', 'suspect_drug', 'causality_assessment', 'time_to_onset_days', 'event_llt', 'report_type', 'reporter_type', 'seriousness', 'alt_u_l'}) and 25 missing columns ({'dose_freq', 'event_duration', 'reporter_qualification', 'drug_indication', 'drug_name', 'alt', 'serious', 'pt', 'weight', 'route_of_admin', 'causality', 'creatinine', 'ast', 'concomitant_drugs', 'therapy_duration', 'soc', 'action_drug', 'bilirubin', 'fda_dt', 'report_source', 'llt', 'bun', 'ttp_days', 'hlgt', 'hlt'}).
This happened while the csv dataset builder was generating data using
hf://datasets/PrashantRGore/synthetic-faers-1m-v2/synthetic_faers_1m_v2.csv (at revision b57df3af2c006f15ca7ba8ee68746c2ba356bf22)
Please either edit the data files to have matching columns, or separate them into different configurations (see docs at https://hf.co/docs/hub/datasets-manual-configuration#multiple-configurations)
Traceback: Traceback (most recent call last):
File "/usr/local/lib/python3.12/site-packages/datasets/builder.py", line 1831, in _prepare_split_single
writer.write_table(table)
File "/usr/local/lib/python3.12/site-packages/datasets/arrow_writer.py", line 714, in write_table
pa_table = table_cast(pa_table, self._schema)
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
File "/usr/local/lib/python3.12/site-packages/datasets/table.py", line 2272, in table_cast
return cast_table_to_schema(table, schema)
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
File "/usr/local/lib/python3.12/site-packages/datasets/table.py", line 2218, in cast_table_to_schema
raise CastError(
datasets.table.CastError: Couldn't cast
case_id: string
receive_date: string
country: string
age: int64
age_group: string
sex: string
weight_kg: double
suspect_drug: string
indication: string
route: string
dose: int64
dose_unit: string
dose_frequency: string
treatment_duration_days: double
event_llt: string
event_pt: string
event_hlt: string
event_hlgt: string
event_soc: string
time_to_onset_days: int64
event_duration_days: double
seriousness: string
outcome: string
action_taken: string
dechallenge: string
rechallenge: string
concomitant_medications: string
medical_history: string
reporter_type: string
report_type: string
causality_assessment: string
alt_u_l: double
ast_u_l: double
bilirubin_mg_dl: double
creatinine_mg_dl: double
bun_mg_dl: double
-- schema metadata --
pandas: '{"index_columns": [{"kind": "range", "name": null, "start": 0, "' + 4656
to
{'case_id': Value('string'), 'fda_dt': Value('string'), 'country': Value('string'), 'age': Value('int64'), 'age_group': Value('string'), 'sex': Value('string'), 'weight': Value('float64'), 'drug_name': Value('string'), 'drug_indication': Value('string'), 'route_of_admin': Value('string'), 'dose': Value('int64'), 'dose_unit': Value('string'), 'dose_freq': Value('string'), 'therapy_duration': Value('float64'), 'llt': Value('string'), 'pt': Value('string'), 'hlt': Value('string'), 'hlgt': Value('string'), 'soc': Value('string'), 'ttp_days': Value('int64'), 'event_duration': Value('float64'), 'serious': Value('string'), 'outcome': Value('string'), 'action_drug': Value('string'), 'dechallenge': Value('string'), 'rechallenge': Value('string'), 'concomitant_drugs': Value('string'), 'medical_history': Value('string'), 'reporter_qualification': Value('string'), 'report_source': Value('string'), 'causality': Value('string'), 'alt': Value('float64'), 'ast': Value('float64'), 'bilirubin': Value('float64'), 'creatinine': Value('float64'), 'bun': Value('float64')}
because column names don't match
During handling of the above exception, another exception occurred:
Traceback (most recent call last):
File "/src/services/worker/src/worker/job_runners/config/parquet_and_info.py", line 1339, in compute_config_parquet_and_info_response
parquet_operations = convert_to_parquet(builder)
^^^^^^^^^^^^^^^^^^^^^^^^^^^
File "/src/services/worker/src/worker/job_runners/config/parquet_and_info.py", line 972, in convert_to_parquet
builder.download_and_prepare(
File "/usr/local/lib/python3.12/site-packages/datasets/builder.py", line 894, in download_and_prepare
self._download_and_prepare(
File "/usr/local/lib/python3.12/site-packages/datasets/builder.py", line 970, in _download_and_prepare
self._prepare_split(split_generator, **prepare_split_kwargs)
File "/usr/local/lib/python3.12/site-packages/datasets/builder.py", line 1702, in _prepare_split
for job_id, done, content in self._prepare_split_single(
^^^^^^^^^^^^^^^^^^^^^^^^^^^
File "/usr/local/lib/python3.12/site-packages/datasets/builder.py", line 1833, in _prepare_split_single
raise DatasetGenerationCastError.from_cast_error(
datasets.exceptions.DatasetGenerationCastError: An error occurred while generating the dataset
All the data files must have the same columns, but at some point there are 25 new columns ({'event_soc', 'event_pt', 'concomitant_medications', 'bun_mg_dl', 'bilirubin_mg_dl', 'ast_u_l', 'receive_date', 'creatinine_mg_dl', 'action_taken', 'event_hlgt', 'event_duration_days', 'route', 'treatment_duration_days', 'event_hlt', 'weight_kg', 'dose_frequency', 'indication', 'suspect_drug', 'causality_assessment', 'time_to_onset_days', 'event_llt', 'report_type', 'reporter_type', 'seriousness', 'alt_u_l'}) and 25 missing columns ({'dose_freq', 'event_duration', 'reporter_qualification', 'drug_indication', 'drug_name', 'alt', 'serious', 'pt', 'weight', 'route_of_admin', 'causality', 'creatinine', 'ast', 'concomitant_drugs', 'therapy_duration', 'soc', 'action_drug', 'bilirubin', 'fda_dt', 'report_source', 'llt', 'bun', 'ttp_days', 'hlgt', 'hlt'}).
This happened while the csv dataset builder was generating data using
hf://datasets/PrashantRGore/synthetic-faers-1m-v2/synthetic_faers_1m_v2.csv (at revision b57df3af2c006f15ca7ba8ee68746c2ba356bf22)
Please either edit the data files to have matching columns, or separate them into different configurations (see docs at https://hf.co/docs/hub/datasets-manual-configuration#multiple-configurations)Need help to make the dataset viewer work? Make sure to review how to configure the dataset viewer, and open a discussion for direct support.
case_id string | fda_dt string | country string | age int64 | age_group string | sex string | weight float64 | drug_name string | drug_indication string | route_of_admin string | dose int64 | dose_unit string | dose_freq string | therapy_duration float64 | llt string | pt string | hlt string | hlgt string | soc string | ttp_days int64 | event_duration float64 | serious string | outcome string | action_drug string | dechallenge string | rechallenge string | concomitant_drugs string | medical_history string | reporter_qualification string | report_source string | causality string | alt float64 | ast float64 | bilirubin float64 | creatinine float64 | bun float64 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
E787C9A1FC17D940 | 2023-04-19 | CHN | 52 | adult | Unknown | null | Hematocare | Hypothyroidism | Subcutaneous | 5 | mg | Four times daily | 688 | High blood pressure | Deep vein thrombosis | Hypertension | Vascular hypertensive disorders | Vascular disorders | 29 | null | Non-serious | Recovered/Resolved | Drug withdrawn | Positive | Not applicable | Aspirin | null | Physician | Spontaneous | Probable/Likely | 12 | 12 | 0.4 | 1 | 16 |
A29236736650CAB3 | 2021-10-30 | POL | 45 | adult | Male | 110.5 | Osteostrong | Bipolar disorder | Intravenous | 50 | mg | Four times daily | 348 | AKI | Acute kidney injury | Acute renal failures | Renal failures and impairments | Renal and urinary disorders | 7 | 69 | Non-serious | Recovered/Resolved | Drug withdrawn | Positive | Not applicable | Hydrochlorothiazide | null | Consumer | Clinical trial | Probable/Likely | 15 | null | 0.5 | 7.1 | 46 |
837A1C25D1B0ED72 | 2021-09-12 | ITA | 92 | elderly | Female | null | Hematocare | COPD | Subcutaneous | 1 | mg | As needed | 556 | Hepatic injury | Hepatotoxicity | Liver failures and associated disorders | Liver disorders | Hepatobiliary disorders | 45 | null | Non-serious | Recovering/Resolving | Not applicable | Not applicable | Not applicable | null | Hyperlipidemia; Alcohol use disorder; Chronic kidney disease; Previous myocardial infarction | Physician | Spontaneous | Possible | 340 | null | 9.5 | 0.9 | 15 |
BF1523DD99667C0D | 2021-10-03 | USA | 47 | adult | Male | 115 | Vasodilate | Schizophrenia | Ophthalmic | 1 | mg | Once daily | null | Erythema multiforme | Toxic epidermal necrolysis | Rashes, eruptions and exanthems NEC | Epidermal and dermal conditions | Skin and subcutaneous tissue disorders | 5 | 45 | Non-serious | Recovered with sequelae | Dose reduced | Not applicable | Not applicable | null | Peripheral vascular disease; Hypothyroidism; Previous myocardial infarction | Consumer | Spontaneous | Possible | 45 | null | 1.1 | 1.2 | 9 |
F470F722F96A2FF7 | 2021-03-08 | GBR | 19 | adult | Female | 94.4 | Cardiomax | Rheumatoid arthritis | Intramuscular | 5 | mg | Twice daily | 453 | Hyperthyroidism | Diabetes mellitus | Hyperglycaemic conditions NEC | Glucose metabolism disorders | Endocrine disorders | 174 | null | Other medically important condition | Recovered with sequelae | Dose increased | Not applicable | Not applicable | Pantoprazole; Hydrochlorothiazide | null | Pharmacist | Spontaneous | Unlikely | 33 | 35 | 0.1 | 1.1 | 12 |
785B2438894CDCFA | 2025-08-05 | ESP | 89 | elderly | Male | 111.7 | Eyeprotect | Rheumatoid arthritis | Topical | 2 | mg | Three times daily | null | AKI | Acute kidney injury | Acute renal failures | Renal failures and impairments | Renal and urinary disorders | 2 | 61 | Disability | Recovered/Resolved | Not applicable | Not applicable | Not applicable | Warfarin; Aspirin | Osteoarthritis; Depression | Other health professional | Literature | Possible | 27 | 26 | 1.2 | null | null |
5A0796C50364BAA5 | 2023-04-29 | CAN | 58 | adult | Unknown | 58.1 | Immunoshield | Type 2 diabetes | Topical | 1 | mg | As needed | null | Blood clot in leg | Hypertension | Hypertension | Vascular hypertensive disorders | Vascular disorders | 14 | 9 | Non-serious | Recovered with sequelae | Dose not changed | Not applicable | Not applicable | Atorvastatin; Ciprofloxacin | Chronic pain; Hypothyroidism; Heart failure | Lawyer | Spontaneous | Possible | 28 | 16 | 1.1 | 1.2 | 11 |
BEA3CC1D4F66B39B | 2022-04-26 | NLD | 47 | adult | Unknown | null | Eyeprotect | Anxiety | Intravenous | 250 | mg | As needed | 680 | New malignancy | Carcinoma | Leukaemias NEC | Malignant neoplasms | Neoplasms benign, malignant and unspecified | 54 | null | Non-serious | Recovered/Resolved | Drug withdrawn | Positive | Not applicable | Lisinopril | Hepatitis B | Consumer | Spontaneous | Possible | 34 | null | 0.9 | 1.2 | 19 |
A3B710F35B3DBE9E | 2022-04-13 | BEL | 78 | elderly | Unknown | null | Thyroregul | Schizophrenia | Inhalation | 10 | mg | As needed | 517 | Blood clot in lung | Pulmonary embolism | Dyspnoea and related conditions | Respiratory disorders NEC | Respiratory, thoracic and mediastinal disorders | 171 | null | Non-serious | Not recovered/Not resolved | Dose reduced | Not applicable | Not applicable | Warfarin | Gastroesophageal reflux disease; Occupational radiation exposure; Chronic pain | Lawyer | Spontaneous | Unlikely | 27 | 32 | 0.4 | null | 10 |
73BDA39A3B797270 | 2021-10-29 | AUT | 9 | child | Unknown | 46.2 | Cardiomax | Infection | Ophthalmic | 10 | mg | Four times daily | null | Low WBC | Agranulocytosis | Neutropenias | White blood cell disorders | Blood and lymphatic system disorders | 13 | 7 | Non-serious | Not recovered/Not resolved | Dose increased | Not applicable | Not applicable | Acetaminophen; Warfarin | Gastroesophageal reflux disease | Lawyer | Spontaneous | Possible | 34 | 31 | 0.9 | 1.2 | null |
4EF830077EAB9CC6 | 2023-11-19 | RUS | 21 | adult | Male | 76.5 | Diabecontrol | Rheumatoid arthritis | Topical | 5 | mg | Four times daily | 259 | Hepatocellular injury | Hepatotoxicity | Liver failures and associated disorders | Liver disorders | Hepatobiliary disorders | 24 | 70 | Hospitalization - initial or prolonged | Recovered/Resolved | Drug withdrawn | Unknown | Not applicable | null | null | Pharmacist | Spontaneous | Possible | 120 | null | 10.5 | 0.8 | 19 |
57C98C2AA1EA87E7 | 2024-11-12 | POL | 53 | adult | Unknown | null | Psychostabil | Migraine prophylaxis | Subcutaneous | 1 | mg | As needed | 708 | Acute leukemia | Acute myeloid leukaemia | Leukaemias NEC | Malignant neoplasms | Neoplasms benign, malignant and unspecified | 23 | 39 | Non-serious | Recovering/Resolving | Drug withdrawn | Unknown | Not applicable | Albuterol; Hydrochlorothiazide | Anxiety disorder | Physician | Spontaneous | Possible | null | 23 | 0.2 | 1 | null |
FBC0C579BD045CEF | 2024-03-06 | JPN | 80 | elderly | Unknown | null | Diabecontrol | GERD | Intravenous | 250 | mg | Four times daily | 250 | Cannot sleep | Anxiety | Depressive disorders | Mental disorders NEC | Psychiatric disorders | 22 | null | Disability | Recovered with sequelae | Drug withdrawn | Positive | Not applicable | Acetaminophen | Gastroesophageal reflux disease; Migraine | Physician | Spontaneous | Probable/Likely | null | 33 | null | 0.9 | 14 |
A5BDDF88AE65A095 | 2024-01-13 | SWE | 51 | adult | Unknown | 79.8 | Diabecontrol | Osteoarthritis | Rectal | 5 | mg | Three times daily | 258 | Convulsion | Headache | Headaches | Neurological disorders NEC | Nervous system disorders | 7 | null | Congenital anomaly | Unknown | Dose not changed | Not applicable | Not applicable | null | Gastroesophageal reflux disease; Benign prostatic hyperplasia | Consumer | Regulatory authority | Possible | 43 | 13 | 0.4 | 0.8 | 9 |
6C88310FB016B892 | 2021-05-07 | RUS | 20 | adult | Female | 69.9 | Diabecontrol | Anxiety | Oral | 50 | mg | Four times daily | null | DILI | Jaundice | Liver failures and associated disorders | Liver disorders | Hepatobiliary disorders | 3 | null | Non-serious | Recovered/Resolved | Drug withdrawn | Positive | Not applicable | Atorvastatin; Hydrochlorothiazide; Prednisone | Occupational chemical exposure; Previous myocardial infarction | Pharmacist | Clinical trial | Probable/Likely | 489 | 543 | 9.4 | null | null |
772C929AC2342465 | 2021-08-20 | DNK | 26 | adult | Unknown | 78.6 | Painaway | COPD | Oral | 25 | mg | Three times daily | 724 | Vomiting symptom | Gastrointestinal haemorrhage | Nausea and vomiting symptoms | Gastrointestinal signs and symptoms | Gastrointestinal disorders | 147 | 10 | Non-serious | Recovered with sequelae | Dose not changed | Not applicable | Not applicable | Amoxicillin; Metoprolol | Migraine | Pharmacist | Spontaneous | Unlikely | 27 | null | 1 | 1.2 | null |
409F47B4A2E65357 | 2024-03-11 | JPN | 13 | adolescent | Unknown | 73.1 | Cardiomax | Hyperlipidemia | Subcutaneous | 25 | mg | As needed | 22 | CVA | Stroke | Hypertension | Vascular hypertensive disorders | Vascular disorders | 178 | null | Non-serious | Recovered/Resolved | Dose increased | Not applicable | Not applicable | Furosemide | Osteoporosis | Lawyer | Spontaneous | Unlikely | 41 | 25 | 0.5 | 1.2 | 18 |
19C30D76AA6B6C45 | 2024-01-23 | POL | 26 | adult | Male | null | Thyroregul | Coronary artery disease | Topical | 1 | mg | Twice daily | null | Low hemoglobin | Anemia | Neutropenias | White blood cell disorders | Blood and lymphatic system disorders | 158 | 81 | Non-serious | Recovered/Resolved | Drug withdrawn | Positive | Not applicable | Simvastatin; Atorvastatin | null | Consumer | Clinical trial | Possible | 20 | 10 | 0.2 | 1.2 | 8 |
A72FAEBA9BD08C38 | 2023-03-25 | MEX | 47 | adult | Male | 82 | Hematocare | Schizophrenia | Sublingual | 2 | mg | Once daily | 283 | Wheezing | Dyspnoea | Dyspnoea and related conditions | Respiratory disorders NEC | Respiratory, thoracic and mediastinal disorders | 26 | null | Death | Fatal | Drug withdrawn | Positive | Not applicable | Simvastatin; Omeprazole; Losartan | Anxiety disorder; Depression | Consumer | Clinical trial | Probable/Likely | 34 | 20 | null | 0.9 | null |
44F4DA6CA2153492 | 2021-07-25 | BEL | 70 | elderly | Male | 117.5 | Lipidlow | Rheumatoid arthritis | Intravenous | 500 | mg | Once daily | 539 | Generalized anxiety | Insomnia | Depressive disorders | Mental disorders NEC | Psychiatric disorders | 5 | 53 | Non-serious | Unknown | Drug withdrawn | Not applicable | Not applicable | Acetaminophen | Previous stroke; Hyperlipidemia | Other health professional | Literature | Possible | 44 | 20 | 1.1 | 1 | 10 |
ABAB4B3427295CC2 | 2023-01-15 | ZAF | 25 | adult | Female | 61.6 | Cardiomax | Type 2 diabetes | Inhalation | 1 | mg | Three times daily | null | Decreased blood cells | Pancytopenia | Neutropenias | White blood cell disorders | Blood and lymphatic system disorders | 8 | 68 | Non-serious | Recovering/Resolving | Drug withdrawn | Positive | Not applicable | Amoxicillin | Hepatitis C | Consumer | Spontaneous | Probable/Likely | 39 | 24 | 0.1 | 1.2 | null |
27FD1578D123F555 | 2025-09-11 | FRA | 36 | adult | Female | 120 | Pulmofix | Migraine prophylaxis | Ophthalmic | 5 | mg | As needed | 303 | Loose stools | Diarrhoea | Nausea and vomiting symptoms | Gastrointestinal signs and symptoms | Gastrointestinal disorders | 27 | null | Non-serious | Recovered/Resolved | Not applicable | Not applicable | Not applicable | Metformin; Acetaminophen | Smoking history; Hepatitis B | Other health professional | Clinical trial | Possible | 24 | null | 0.3 | 1.1 | 17 |
6F3EB8ACAB09E582 | 2021-06-07 | IND | 63 | adult | Female | 56.3 | Eyeprotect | Atrial fibrillation | Intramuscular | 2 | mg | null | 553 | Decreased RBC | Thrombocytopenia | Neutropenias | White blood cell disorders | Blood and lymphatic system disorders | 30 | 35 | Non-serious | Recovered/Resolved | Not applicable | Not applicable | Not applicable | Insulin | Depression; Occupational chemical exposure | Physician | Spontaneous | Possible | null | null | 0.8 | 0.9 | 15 |
BDE02EA4D5241E3D | 2023-08-23 | FRA | 56 | adult | Female | 107.6 | Dermafix | GERD | Rectal | 1 | mg | null | 575 | Blood in stool | Nausea | Nausea and vomiting symptoms | Gastrointestinal signs and symptoms | Gastrointestinal disorders | 407 | null | Disability | Recovered with sequelae | Dose reduced | Not applicable | Not applicable | Omeprazole | null | Physician | Spontaneous | Unlikely | null | 17 | 0.2 | 1.1 | 15 |
E1FCEEC20570540D | 2025-10-13 | RUS | 33 | adult | Male | 98.3 | Vasodilate | GERD | Inhalation | 1 | mg | Three times daily | null | Basal cell carcinoma | Lymphoma | Leukaemias NEC | Malignant neoplasms | Neoplasms benign, malignant and unspecified | 13 | 36 | Death | Fatal | Unknown | Not applicable | Not applicable | Lisinopril; Amoxicillin | Previous stroke | Consumer | Regulatory authority | Possible | 13 | 17 | null | 1.2 | null |
11927E0309C1CBAC | 2025-03-16 | FRA | 68 | elderly | Male | 87.8 | Dermafix | Hypertension | Intramuscular | 1 | mg | null | 244 | Eosinophilia | Drug reaction with eosinophilia | Hypersensitivity conditions NEC | Allergic conditions | Immune system disorders | 6 | 34 | Other medically important condition | Recovered/Resolved | Drug withdrawn | Positive | Not applicable | Pantoprazole | null | Consumer | Spontaneous | Probable/Likely | 12 | 39 | 0.7 | null | 14 |
FA8D3B8951A3D545 | 2024-11-10 | FIN | 25 | adult | Unknown | 58.8 | Lipidlow | Hypothyroidism | Inhalation | 10 | mg | null | null | Loose stools | Diarrhoea | Nausea and vomiting symptoms | Gastrointestinal signs and symptoms | Gastrointestinal disorders | 20 | 56 | Other medically important condition | Recovered/Resolved | Dose not changed | Not applicable | Not applicable | Hydrochlorothiazide; Ciprofloxacin | Rheumatoid arthritis; Obesity; Hepatitis B | Pharmacist | Spontaneous | Possible | 39 | null | 0.6 | null | null |
6DCE6F0EAA6CFE42 | 2025-09-25 | FRA | 57 | adult | Unknown | null | Infectoban | Osteoarthritis | Topical | 1 | mg | Three times daily | 615 | Cramping | Diarrhoea | Nausea and vomiting symptoms | Gastrointestinal signs and symptoms | Gastrointestinal disorders | 19 | 65 | Other medically important condition | Recovered/Resolved | Not applicable | Not applicable | Not applicable | Hydrochlorothiazide | Occupational radiation exposure | Other health professional | Spontaneous | Possible | 37 | 34 | 0.8 | 0.6 | 20 |
353ED98700262A43 | 2024-08-08 | ITA | 29 | adult | Male | null | Eyeprotect | Bipolar disorder | Oral | 10 | mg | As needed | 221 | Cytopenia | Leukopenia | Neutropenias | White blood cell disorders | Blood and lymphatic system disorders | 11 | 21 | Non-serious | Not recovered/Not resolved | Dose not changed | Not applicable | Not applicable | Lisinopril | Atrial fibrillation; Chronic kidney disease; Occupational radiation exposure | Consumer | Spontaneous | Possible | 15 | 31 | 0.8 | 0.8 | 12 |
03786152A65949A9 | 2022-10-28 | CAN | 54 | adult | Female | null | Sleepwell | Depression | Transdermal | 5 | mg | Three times daily | 123 | CHF | Cardiac failure | Heart failures NEC | Heart failures | Cardiac disorders | 14 | 23 | Congenital anomaly | Not recovered/Not resolved | Dose increased | Not applicable | Not applicable | Albuterol; Lisinopril | Benign prostatic hyperplasia | Physician | Spontaneous | Possible | 39 | 37 | 0.6 | 1 | null |
D52AF8B08D66FB20 | 2025-02-26 | MEX | 16 | adolescent | Unknown | 50.9 | Anticoag-XR | Hyperlipidemia | Topical | 5 | mg | Three times daily | 227 | Low neutrophils | Pancytopenia | Neutropenias | White blood cell disorders | Blood and lymphatic system disorders | 50 | 66 | Non-serious | Recovering/Resolving | Drug withdrawn | Not applicable | Not applicable | Ibuprofen | COPD; Coronary artery disease; Atrial fibrillation | Other health professional | Spontaneous | Unlikely | 19 | null | 1.1 | 0.9 | 16 |
3E7BD717FF124F0E | 2021-11-21 | FIN | 28 | adult | Female | 54.8 | Oncotreat | Asthma | Ophthalmic | 1 | mg | Three times daily | null | Hepatic dysfunction | Hepatic failure | Liver failures and associated disorders | Liver disorders | Hepatobiliary disorders | 15 | 5 | Hospitalization - initial or prolonged | Recovered/Resolved | Not applicable | Not applicable | Not applicable | Acetaminophen; Clopidogrel | Osteoporosis | Consumer | Regulatory authority | Possible | 142 | 675 | 5.8 | null | 8 |
5E515EA76957E281 | 2024-07-19 | BRA | 48 | adult | Male | 86.6 | Arthrorelief | COPD | Topical | 10 | mg | Three times daily | null | Septic shock | Sepsis | Bacterial infections NEC | Infections NEC | Infections and infestations | 21 | 83 | Hospitalization - initial or prolonged | Recovered/Resolved | Dose not changed | Not applicable | Not applicable | Ciprofloxacin | Hepatitis C; Previous myocardial infarction; Alcohol use disorder | Pharmacist | Spontaneous | Possible | 19 | 19 | 0.9 | 1 | 11 |
668DE02B9761605D | 2024-12-09 | CHN | 95 | elderly | Unknown | 56.5 | Anticoag-XR | Osteoarthritis | Oral | 100 | mg | Three times daily | 185 | Erythema multiforme | Toxic epidermal necrolysis | Rashes, eruptions and exanthems NEC | Epidermal and dermal conditions | Skin and subcutaneous tissue disorders | 25 | 63 | Life-threatening | Recovered/Resolved | Drug withdrawn | Not applicable | Not applicable | Hydrochlorothiazide | Hepatitis B; Chronic pain; Diabetes mellitus type 2 | Other health professional | Literature | Possible | 18 | null | 1 | null | null |
F8A93FECC5A98328 | 2021-01-20 | ZAF | 74 | elderly | Female | 66.7 | Hematocare | Osteoarthritis | Ophthalmic | 10 | mg | Four times daily | 289 | Shortness of breath | Respiratory failure | Dyspnoea and related conditions | Respiratory disorders NEC | Respiratory, thoracic and mediastinal disorders | 14 | null | Non-serious | Not recovered/Not resolved | Drug withdrawn | Positive | Not applicable | Hydrochlorothiazide; Atorvastatin | Chronic pain; Alcohol use disorder | Physician | Spontaneous | Probable/Likely | 20 | 38 | null | 1.2 | 12 |
B16C43B9E05EE8CC | 2025-07-11 | IND | 36 | adult | Unknown | 108.7 | Neurobalance | Depression | Oral | 50 | mg | Four times daily | null | Oliguria | Acute kidney injury | Acute renal failures | Renal failures and impairments | Renal and urinary disorders | 151 | null | Non-serious | Recovered with sequelae | Drug withdrawn | Positive | Unknown | Prednisone; Atorvastatin | COPD; Hypothyroidism | Physician | Spontaneous | Possible | 36 | 29 | 0.2 | null | 90 |
ED35BFC66A9EF391 | 2023-11-07 | DEU | 58 | adult | Female | null | Anticoag-XR | Hypothyroidism | Sublingual | 25 | mg | null | 21 | SOB | Pneumonitis | Dyspnoea and related conditions | Respiratory disorders NEC | Respiratory, thoracic and mediastinal disorders | 42 | 21 | Non-serious | Recovered/Resolved | Dose not changed | Not applicable | Not applicable | Lisinopril | Benign prostatic hyperplasia | Physician | Clinical trial | Unlikely | null | 21 | null | 1.1 | 18 |
7F22EE40E9747174 | 2024-10-25 | BEL | 28 | adult | Female | null | Psychostabil | Hypothyroidism | Rectal | 5 | mg | Once daily | 663 | Hives | Urticaria | Rashes, eruptions and exanthems NEC | Epidermal and dermal conditions | Skin and subcutaneous tissue disorders | 28 | 7 | Non-serious | Recovered/Resolved | Drug withdrawn | Positive | Not applicable | Gabapentin; Levothyroxine | Sleep apnea; Peripheral vascular disease; Anxiety disorder; Hepatitis C | Consumer | Spontaneous | Probable/Likely | 15 | 12 | null | null | 12 |
937A3483B70E66A1 | 2023-03-14 | FIN | 9 | child | Female | null | Hepatosan | Hyperlipidemia | Topical | 5 | mg | As needed | 696 | Skin rash | Toxic epidermal necrolysis | Rashes, eruptions and exanthems NEC | Epidermal and dermal conditions | Skin and subcutaneous tissue disorders | 327 | null | Non-serious | Recovered/Resolved | Drug withdrawn | Positive | Not applicable | Pantoprazole | null | Pharmacist | Spontaneous | Possible | 33 | null | 0.3 | 0.8 | null |
1E76B4CE76D8D58A | 2025-04-11 | CAN | 33 | adult | Female | 70 | Dermatopin | Depression | Intravenous | 500 | mg | Twice daily | null | Mixed hepatic injury | Hepatitis acute | Liver failures and associated disorders | Liver disorders | Hepatobiliary disorders | 112 | null | Death | Fatal | Dose increased | Not applicable | Not applicable | Insulin | Peripheral vascular disease; Hepatitis C; Previous stroke | Pharmacist | Clinical trial | Unlikely | null | 295 | 4.7 | 0.9 | 14 |
AADDD20E42CBAAFD | 2023-07-01 | DEU | 52 | adult | Unknown | null | Neurobalance | Rheumatoid arthritis | Intravenous | 500 | mg | Four times daily | 697 | Muscle fatigue | Rhabdomyolysis | Myopathies | Muscle disorders | Musculoskeletal and connective tissue disorders | 29 | null | Non-serious | Recovered/Resolved | Unknown | Not applicable | Not applicable | Metformin | Chronic pain; Atrial fibrillation; Hypothyroidism | Pharmacist | Spontaneous | Possible | 24 | 40 | null | 0.7 | null |
A5EFF1ED7A43BCE5 | 2022-08-25 | IND | 62 | adult | Unknown | 100.4 | Lipidlow | Type 2 diabetes | Oral | 10 | mg | Once daily | 657 | Facial swelling | Angioedema | Hypersensitivity conditions NEC | Allergic conditions | Immune system disorders | 7 | 74 | Non-serious | Recovering/Resolving | Dose reduced | Not applicable | Not applicable | Insulin; Ibuprofen | Sleep apnea; COPD; Occupational chemical exposure; Heart failure | Lawyer | Spontaneous | Possible | 14 | 15 | null | 1 | 18 |
7D63D54087253868 | 2025-07-18 | AUS | 14 | adolescent | Female | 45.5 | Neurobalance | Pain management | Oral | 50 | mg | Four times daily | 631 | Bronchial constriction | Respiratory failure | Dyspnoea and related conditions | Respiratory disorders NEC | Respiratory, thoracic and mediastinal disorders | 28 | null | Non-serious | Recovered with sequelae | Dose not changed | Not applicable | Not applicable | null | Chronic pain | Lawyer | Spontaneous | Possible | 29 | 12 | 0.7 | 0.8 | 7 |
4469ED65369AF93A | 2020-12-17 | BRA | 13 | adolescent | Female | 72.7 | Hepatosan | Migraine prophylaxis | Oral | 1,000 | mg | Twice daily | null | Hyperthyroidism | Diabetes mellitus | Hyperglycaemic conditions NEC | Glucose metabolism disorders | Endocrine disorders | 13 | 65 | Non-serious | Recovering/Resolving | Not applicable | Not applicable | Not applicable | Acetaminophen; Atorvastatin | null | Physician | Spontaneous | Possible | 31 | 21 | 0.3 | null | 9 |
CEADD96423260391 | 2021-11-28 | CHE | 74 | elderly | Unknown | null | Oncotreat | Seizure disorder | Inhalation | 25 | mg | As needed | null | Elevated CPK | Back pain | Myopathies | Muscle disorders | Musculoskeletal and connective tissue disorders | 107 | null | Non-serious | Recovered/Resolved | Dose not changed | Not applicable | Not applicable | Pantoprazole; Insulin; Ciprofloxacin | Previous stroke; Hypertension; Previous myocardial infarction | Lawyer | Spontaneous | Unlikely | 24 | 28 | 0.7 | 1.1 | 20 |
FB7454AF6380AF6B | 2023-07-29 | NZL | 61 | adult | Unknown | 78.7 | Painaway | Stroke prevention | Oral | 20 | mg | As needed | 213 | Anaphylactic shock | Anaphylactic reaction | Hypersensitivity conditions NEC | Allergic conditions | Immune system disorders | 22 | 62 | Non-serious | Recovered/Resolved | Drug withdrawn | Unknown | Not applicable | Albuterol | Alcohol use disorder; Benign prostatic hyperplasia | Other health professional | Spontaneous | Possible | 22 | 18 | 0.3 | 0.8 | 10 |
30000BCEFBB1E0D9 | 2025-10-13 | TUR | 56 | adult | Female | null | Arthrorelief | Infection | Intramuscular | 5 | mg | Once daily | 295 | Hepatocellular injury | Hepatotoxicity | Liver failures and associated disorders | Liver disorders | Hepatobiliary disorders | 15 | 84 | Disability | Recovered/Resolved | Not applicable | Not applicable | Not applicable | Hydrochlorothiazide | Atrial fibrillation; Coronary artery disease | Consumer | Clinical trial | Possible | null | null | null | 0.8 | 17 |
9AEB86F5B864388B | 2025-02-02 | IND | 79 | elderly | Female | null | Oncotreat | Bipolar disorder | Oral | 10 | mg | As needed | null | Low blood sugar | Thyroid disorder | Hyperglycaemic conditions NEC | Glucose metabolism disorders | Endocrine disorders | 40 | 23 | Non-serious | Not recovered/Not resolved | Unknown | Not applicable | Not applicable | null | Occupational chemical exposure; Sleep apnea; Chronic kidney disease | Other health professional | Literature | Possible | 10 | null | 1.2 | 1.3 | 14 |
B3BD1928E414F658 | 2025-06-28 | CHE | 59 | adult | Male | 100.3 | Diabecontrol | COPD | Ophthalmic | 2 | mg | Twice daily | 626 | Non-Hodgkin lymphoma | Acute myeloid leukaemia | Leukaemias NEC | Malignant neoplasms | Neoplasms benign, malignant and unspecified | 140 | 66 | Disability | Recovering/Resolving | Drug withdrawn | Positive | Not applicable | Furosemide | Obesity | Other health professional | Regulatory authority | Possible | 29 | null | 0.8 | null | null |
2B89D9B20E213E3A | 2024-12-31 | ITA | 36 | adult | Male | null | Painaway | Depression | Rectal | 25 | mg | Three times daily | null | Hypothyroidism | Thyroid disorder | Hyperglycaemic conditions NEC | Glucose metabolism disorders | Endocrine disorders | 956 | 69 | Non-serious | Not recovered/Not resolved | Dose not changed | Not applicable | Not applicable | Acetaminophen; Lisinopril | Chronic pain; Peripheral vascular disease | Other health professional | Spontaneous | Unlikely | null | 27 | 0.3 | 0.7 | null |
5333134178EA57DC | 2025-06-12 | SWE | 51 | adult | Male | 82 | Vasodilate | Cancer | Transdermal | 1 | mg | Four times daily | 261 | Heart failure | Cardiac failure | Heart failures NEC | Heart failures | Cardiac disorders | 179 | 10 | Hospitalization - initial or prolonged | Not recovered/Not resolved | Dose increased | Not applicable | Not applicable | null | Hepatitis C; Sleep apnea; Diabetes mellitus type 2 | Other health professional | Spontaneous | Possible | 18 | 33 | 0.6 | 0.9 | 13 |
957326EA46B40FB4 | 2022-10-05 | AUS | 53 | adult | Unknown | null | Cardiomax | Infection | Oral | 50 | mg | Four times daily | null | Thyroid dysfunction | Thyroid disorder | Hyperglycaemic conditions NEC | Glucose metabolism disorders | Endocrine disorders | 13 | 30 | Hospitalization - initial or prolonged | Recovered/Resolved | Drug withdrawn | Not applicable | Not applicable | Metformin; Amoxicillin | Occupational radiation exposure | Physician | Spontaneous | Possible | null | 11 | 0.8 | null | null |
3EF675D049109158 | 2022-09-01 | PRT | 90 | elderly | Unknown | null | Dermafix | Rheumatoid arthritis | Subcutaneous | 5 | mg | Twice daily | null | Weakness | Rhabdomyolysis | Myopathies | Muscle disorders | Musculoskeletal and connective tissue disorders | 10 | 36 | Congenital anomaly | Recovered with sequelae | Unknown | Not applicable | Not applicable | Prednisone; Hydrochlorothiazide | Anxiety disorder | Lawyer | Clinical trial | Possible | 30 | null | 0.5 | 0.9 | 11 |
FD9A5886A483DFC5 | 2024-02-19 | FIN | 41 | adult | Female | 67.8 | Nephroguard | Coronary artery disease | Inhalation | 1 | mg | As needed | 196 | Bradycardia | Cardiac failure | Heart failures NEC | Heart failures | Cardiac disorders | 22 | null | Non-serious | Recovered with sequelae | Drug withdrawn | Not applicable | Not applicable | Hydrochlorothiazide; Metoprolol | Alcohol use disorder | Other health professional | Spontaneous | Possible | null | 16 | 0.2 | null | 16 |
89EC5E64989D1E01 | 2021-12-26 | RUS | 37 | adult | Female | 75.2 | Dermatopin | Stroke prevention | Rectal | 5 | mg | null | 380 | Hard stools | Gastrointestinal haemorrhage | Nausea and vomiting symptoms | Gastrointestinal signs and symptoms | Gastrointestinal disorders | 19 | null | Non-serious | Recovered/Resolved | Dose not changed | Not applicable | Not applicable | Ciprofloxacin | Atrial fibrillation | Pharmacist | Spontaneous | Possible | 34 | 17 | 0.8 | 0.8 | 18 |
50F637EECF1F3D2B | 2021-02-19 | TUR | 50 | adult | Male | null | Dermafix | Type 2 diabetes | Oral | 200 | mg | null | null | Convulsion | Headache | Headaches | Neurological disorders NEC | Nervous system disorders | 5 | 2 | Disability | Recovered/Resolved | Dose not changed | Not applicable | Not applicable | Acetaminophen; Simvastatin | Hypertension; Migraine | Consumer | Spontaneous | Possible | 11 | 18 | 0.4 | 1.1 | null |
70A636595BCAFC00 | 2022-10-31 | RUS | 41 | adult | Female | 76.1 | Lipidlow | GERD | Subcutaneous | 5 | mg | null | 670 | High blood pressure | Deep vein thrombosis | Hypertension | Vascular hypertensive disorders | Vascular disorders | 54 | null | Non-serious | Recovering/Resolving | Drug withdrawn | Positive | Positive | Levothyroxine | Alcohol use disorder; Coronary artery disease | Consumer | Literature | Certain | null | 37 | 0.7 | 1.2 | 11 |
14F99AE4E4B593CC | 2021-06-16 | ESP | 64 | adult | Female | 115 | Lipidlow | GERD | Ophthalmic | 10 | mg | As needed | null | Breathing difficulty | Pulmonary embolism | Dyspnoea and related conditions | Respiratory disorders NEC | Respiratory, thoracic and mediastinal disorders | 66 | 89 | Non-serious | Recovering/Resolving | Unknown | Not applicable | Not applicable | null | Smoking history | Physician | Spontaneous | Possible | 35 | null | 0.4 | 0.9 | 13 |
91C416DEA5553E44 | 2023-10-08 | GRC | 23 | adult | Unknown | 60.8 | Osteostrong | Depression | Topical | 5 | mg | Three times daily | null | Elevated transaminases | Hepatotoxicity | Liver failures and associated disorders | Liver disorders | Hepatobiliary disorders | 10 | null | Non-serious | Recovered/Resolved | Drug withdrawn | Positive | Not applicable | Prednisone | null | Physician | Spontaneous | Probable/Likely | 195 | 422 | 1.7 | 1.1 | 15 |
DDB6705FBDFE7BD6 | 2025-02-01 | JPN | 48 | adult | Female | 54.4 | Infectoban | COPD | Rectal | 1 | mg | Three times daily | 258 | Light-headedness | Seizure | Headaches | Neurological disorders NEC | Nervous system disorders | 157 | null | Non-serious | Recovered/Resolved | Drug withdrawn | Positive | Not applicable | Gabapentin; Levothyroxine | Rheumatoid arthritis | Consumer | Spontaneous | Possible | 30 | null | 0.4 | 1.3 | 18 |
9CA35463ED5A8CFE | 2025-10-25 | ESP | 53 | adult | Unknown | 91.5 | Dermafix | Infection | Sublingual | 1 | mg | Four times daily | 726 | Skin peeling | Pruritus | Rashes, eruptions and exanthems NEC | Epidermal and dermal conditions | Skin and subcutaneous tissue disorders | 10 | null | Disability | Recovering/Resolving | Drug withdrawn | Positive | Not applicable | null | Osteoarthritis | Physician | Spontaneous | Probable/Likely | 40 | 27 | 1.1 | 1 | 12 |
9DF41A45AEFCAB99 | 2024-12-24 | POL | 30 | adult | Unknown | null | Osteostrong | Migraine prophylaxis | Inhalation | 10 | mg | null | 11 | Yellow skin | Jaundice | Liver failures and associated disorders | Liver disorders | Hepatobiliary disorders | 17 | 9 | Non-serious | Recovering/Resolving | Drug withdrawn | Positive | Not applicable | Azithromycin; Clopidogrel | Hypertension | Lawyer | Spontaneous | Probable/Likely | 525 | null | null | 0.8 | 10 |
DE41841676D12418 | 2021-10-13 | FRA | 1 | child | Unknown | null | Dermafix | Anxiety | Subcutaneous | 25 | mg | Twice daily | null | Skin rash | Toxic epidermal necrolysis | Rashes, eruptions and exanthems NEC | Epidermal and dermal conditions | Skin and subcutaneous tissue disorders | 14 | 60 | Disability | Recovering/Resolving | Drug withdrawn | Negative | Not applicable | Ciprofloxacin | Asthma; Obesity | Consumer | Spontaneous | Unlikely | 10 | 16 | 0.9 | 1 | null |
6F5AD8AF068AD6F2 | 2024-06-15 | FRA | 57 | adult | Unknown | null | Arthrorelief | Osteoarthritis | Rectal | 25 | mg | Twice daily | null | Watery stools | Diarrhoea | Nausea and vomiting symptoms | Gastrointestinal signs and symptoms | Gastrointestinal disorders | 785 | null | Non-serious | Recovered/Resolved | Drug withdrawn | Positive | Not applicable | null | Previous myocardial infarction | Pharmacist | Spontaneous | Possible | null | 30 | 1.1 | null | null |
201BEA405C92AAF7 | 2021-10-17 | FIN | 19 | adolescent | Unknown | 117.5 | Painaway | Atrial fibrillation | Rectal | 10 | mg | Four times daily | null | SJS | Toxic epidermal necrolysis | Rashes, eruptions and exanthems NEC | Epidermal and dermal conditions | Skin and subcutaneous tissue disorders | 1 | 29 | Hospitalization - initial or prolonged | Recovered/Resolved | Drug withdrawn | Not applicable | Not applicable | Simvastatin | Coronary artery disease; Osteoporosis | Physician | Spontaneous | Possible | 44 | 21 | 0.9 | null | null |
A2BDEA67E37F41F5 | 2021-11-20 | PRT | 24 | adult | Male | 110.6 | Pulmofix | Insomnia | Ophthalmic | 5 | mg | null | 648 | Blood clot in lung | Pulmonary embolism | Dyspnoea and related conditions | Respiratory disorders NEC | Respiratory, thoracic and mediastinal disorders | 5 | null | Non-serious | Not recovered/Not resolved | Dose not changed | Not applicable | Not applicable | Acetaminophen | Depression; Peripheral vascular disease | Other health professional | Spontaneous | Possible | 27 | 26 | null | 1.3 | 7 |
F5B347856E8CCB0E | 2024-10-09 | FIN | 90 | elderly | Unknown | null | Immunoshield | Bipolar disorder | Topical | 10 | mg | Four times daily | 78 | New malignancy | Carcinoma | Leukaemias NEC | Malignant neoplasms | Neoplasms benign, malignant and unspecified | 54 | null | Non-serious | Recovered/Resolved | Unknown | Not applicable | Not applicable | Simvastatin | Hypertension | Physician | Clinical trial | Unlikely | 39 | 32 | 0.2 | 0.8 | 10 |
627200A91C8E661A | 2024-11-22 | GRC | 91 | elderly | Unknown | null | Vasodilate | Hypertension | Intravenous | 100 | mg | Four times daily | null | Heart failure | Cardiac failure | Heart failures NEC | Heart failures | Cardiac disorders | 619 | 26 | Non-serious | Recovered with sequelae | Not applicable | Not applicable | Not applicable | Furosemide | null | Other health professional | Spontaneous | Unlikely | 33 | null | 0.5 | null | null |
F70365BF2ACAF087 | 2024-09-22 | AUT | 18 | adult | Female | 107.2 | Neurobalance | Heart failure | Intravenous | 100 | mg | Four times daily | 92 | Jaundice symptom | Drug-induced liver injury | Liver failures and associated disorders | Liver disorders | Hepatobiliary disorders | 12 | null | Life-threatening | Recovering/Resolving | Dose not changed | Not applicable | Not applicable | null | Previous myocardial infarction; Previous stroke | Pharmacist | Spontaneous | Possible | 318 | 245 | 9.8 | 0.8 | 9 |
D3E7D7BC23D3B753 | 2021-10-16 | CHE | 22 | adult | Unknown | null | Glucobalance | COPD | Oral | 50 | mg | Twice daily | 531 | UTI | Urinary tract infection | Bacterial infections NEC | Infections NEC | Infections and infestations | 24 | null | Death | Fatal | Dose not changed | Not applicable | Not applicable | Warfarin; Simvastatin | COPD | Lawyer | Spontaneous | Possible | 14 | 10 | null | 1.2 | 12 |
AC0D5C4253EC96BD | 2021-01-30 | GRC | 1 | infant | Male | null | Psychostabil | Chronic kidney disease | Transdermal | 25 | mg | Four times daily | 434 | Lung inflammation | Dyspnoea | Dyspnoea and related conditions | Respiratory disorders NEC | Respiratory, thoracic and mediastinal disorders | 18 | null | Non-serious | Recovered/Resolved | Dose reduced | Not applicable | Not applicable | Metoprolol | Atrial fibrillation; Migraine; Depression; Osteoarthritis | Consumer | Spontaneous | Possible | 14 | 23 | null | 0.7 | 14 |
26B0B99A09EAA0CC | 2022-12-20 | BEL | 11 | adolescent | Female | 29.9 | Anticoag-XR | Stroke prevention | Transdermal | 2 | mg | Three times daily | 130 | Fainting | Headache | Headaches | Neurological disorders NEC | Nervous system disorders | 61 | null | Disability | Recovered/Resolved | Drug withdrawn | Negative | Not applicable | Lisinopril | Chronic pain | Other health professional | Spontaneous | Unlikely | 20 | 18 | 1.1 | 0.7 | null |
A7B6846198108FAC | 2022-10-11 | CHE | 90 | elderly | Unknown | 88.7 | Osteostrong | Atrial fibrillation | Subcutaneous | 5 | mg | Twice daily | 427 | Difficulty defecating | Gastrointestinal haemorrhage | Nausea and vomiting symptoms | Gastrointestinal signs and symptoms | Gastrointestinal disorders | 3 | null | Non-serious | Recovering/Resolving | Unknown | Not applicable | Not applicable | null | Diabetes mellitus type 2; Osteoarthritis; Hyperlipidemia | Lawyer | Literature | Possible | 29 | 27 | 0.5 | 1.1 | 10 |
3BF5D05671C2815E | 2022-05-11 | USA | 71 | elderly | Female | 50.4 | Pulmofix | Hypothyroidism | Inhalation | 1 | mg | null | 2 | Low blood pressure | Hypertension | Hypertension | Vascular hypertensive disorders | Vascular disorders | 24 | null | Congenital anomaly | Unknown | Dose reduced | Not applicable | Not applicable | Omeprazole; Azithromycin; Furosemide | null | Pharmacist | Literature | Possible | 43 | 38 | null | null | 20 |
6C26F26EAB47642A | 2023-03-19 | IND | 95 | elderly | Unknown | null | Diabecontrol | Coronary artery disease | Transdermal | 2 | mg | null | null | Elevated creatinine | Renal impairment | Acute renal failures | Renal failures and impairments | Renal and urinary disorders | 180 | null | Life-threatening | Recovered/Resolved | Dose reduced | Not applicable | Not applicable | null | Occupational radiation exposure | Pharmacist | Spontaneous | Possible | 39 | null | 1 | 6.1 | 52 |
0AA9692ECFF9B273 | 2023-05-21 | ISR | 33 | adult | Female | 52.2 | Vasodilate | Hypothyroidism | Sublingual | 2 | mg | Once daily | 474 | Jaundice symptom | Drug-induced liver injury | Liver failures and associated disorders | Liver disorders | Hepatobiliary disorders | 66 | 16 | Life-threatening | Recovered/Resolved | Not applicable | Not applicable | Not applicable | Ibuprofen | Hyperlipidemia; Osteoporosis; Gastroesophageal reflux disease | Physician | Spontaneous | Unlikely | null | 544 | 2.7 | null | null |
62BE3BD015D18472 | 2025-09-07 | JPN | 39 | adult | Female | null | Vasodilate | Depression | Oral | 25 | mg | Three times daily | 511 | Productive cough | Pneumonitis | Dyspnoea and related conditions | Respiratory disorders NEC | Respiratory, thoracic and mediastinal disorders | 153 | 8 | Disability | Recovered/Resolved | Drug withdrawn | Not applicable | Not applicable | Ibuprofen | Migraine; Occupational chemical exposure; Hypertension; Osteoarthritis | Other health professional | Spontaneous | Unlikely | 41 | 28 | null | null | 19 |
A40510A9EEF7513B | 2022-07-28 | SWE | 67 | elderly | Female | 96 | Eyeprotect | Type 2 diabetes | Subcutaneous | 25 | mg | Four times daily | 364 | Erythematous rash | Dermatitis | Rashes, eruptions and exanthems NEC | Epidermal and dermal conditions | Skin and subcutaneous tissue disorders | 19 | null | Non-serious | Recovering/Resolving | Unknown | Not applicable | Not applicable | null | Osteoporosis; Atrial fibrillation | Consumer | Regulatory authority | Possible | 41 | 15 | null | 0.8 | 7 |
CAA451D756274CD1 | 2025-11-19 | NZL | 64 | elderly | Unknown | 60.3 | Neurobalance | Infection | Intravenous | 1,000 | mg | Three times daily | 75 | Decreased blood cells | Pancytopenia | Neutropenias | White blood cell disorders | Blood and lymphatic system disorders | 132 | 13 | Hospitalization - initial or prolonged | Recovered/Resolved | Drug withdrawn | Unknown | Not applicable | Simvastatin; Ibuprofen | Peripheral vascular disease | Consumer | Spontaneous | Unlikely | null | 28 | 0.5 | null | 7 |
8E9BD130EC55CCD8 | 2023-08-17 | NZL | 56 | adult | Male | 94.8 | Painaway | Depression | Inhalation | 1 | mg | Twice daily | 356 | Difficulty defecating | Gastrointestinal haemorrhage | Nausea and vomiting symptoms | Gastrointestinal signs and symptoms | Gastrointestinal disorders | 29 | 12 | Non-serious | Recovering/Resolving | Dose not changed | Not applicable | Not applicable | Aspirin | COPD | Physician | Spontaneous | Possible | 16 | 11 | 0.9 | 1.2 | 13 |
88E417428472EAE3 | 2025-03-27 | KOR | 44 | adult | Male | null | Cardiomax | Rheumatoid arthritis | Transdermal | 1 | mg | Once daily | null | TEN | Rash | Rashes, eruptions and exanthems NEC | Epidermal and dermal conditions | Skin and subcutaneous tissue disorders | 72 | 10 | Non-serious | Recovered with sequelae | Drug withdrawn | Positive | Not applicable | Aspirin | Previous stroke | Pharmacist | Spontaneous | Possible | null | 13 | 1.2 | 1 | 15 |
662A831726332AA5 | 2021-06-10 | TUR | 39 | adult | Female | 79.9 | Dermafix | Bipolar disorder | Ophthalmic | 10 | mg | Twice daily | null | Myocardial infarction | Cardiac failure | Heart failures NEC | Heart failures | Cardiac disorders | 21 | null | Non-serious | Recovered/Resolved | Drug withdrawn | Not applicable | Not applicable | Amoxicillin | Previous stroke | Consumer | Spontaneous | Possible | 33 | null | 0.1 | 0.8 | null |
74268041C9F7CF42 | 2022-07-16 | TUR | 82 | elderly | Female | 88.8 | Anticoag-XR | Atrial fibrillation | Sublingual | 10 | mg | As needed | 242 | Suicidal thoughts | Insomnia | Depressive disorders | Mental disorders NEC | Psychiatric disorders | 13 | 5 | Non-serious | Recovered with sequelae | Not applicable | Not applicable | Not applicable | Acetaminophen; Omeprazole | null | Lawyer | Spontaneous | Possible | 20 | null | null | null | 20 |
5E225B62E71609D9 | 2022-12-16 | BEL | 45 | adult | Female | 72.8 | Vasodilate | Hypertension | Ophthalmic | 25 | mg | As needed | null | Acute renal failure | Renal failure acute | Acute renal failures | Renal failures and impairments | Renal and urinary disorders | 5 | 73 | Non-serious | Not recovered/Not resolved | Unknown | Not applicable | Not applicable | Pantoprazole; Atorvastatin; Insulin | Hepatitis B; Anxiety disorder; Rheumatoid arthritis | Other health professional | Spontaneous | Possible | 41 | null | null | 5.5 | 29 |
4C07091CDA18813C | 2025-10-20 | ISR | 39 | adult | Female | null | Urocare | Cancer | Intravenous | 100 | mg | null | null | Clinical depression | Hallucination | Depressive disorders | Mental disorders NEC | Psychiatric disorders | 113 | null | Non-serious | Recovering/Resolving | Drug withdrawn | Positive | Not applicable | Simvastatin | Alcohol use disorder; Anxiety disorder | Physician | Spontaneous | Possible | null | 32 | 0.2 | null | 10 |
99A0575903ABA10A | 2021-08-27 | NZL | 42 | adult | Unknown | 85.4 | Dermatopin | Cancer | Oral | 25 | mg | null | null | Bacterial pneumonia | Urinary tract infection | Bacterial infections NEC | Infections NEC | Infections and infestations | 28 | 61 | Non-serious | Recovered/Resolved | Drug withdrawn | Not applicable | Not applicable | Azithromycin; Lisinopril | Osteoarthritis | Physician | Spontaneous | Possible | 23 | null | 0.3 | 1 | 19 |
49EC66E68ACB2777 | 2025-05-28 | ISR | 37 | adult | Female | 79.7 | Arthrorelief | Coronary artery disease | Transdermal | 2 | mg | Four times daily | 310 | Cerebrovascular accident | Hypertension | Hypertension | Vascular hypertensive disorders | Vascular disorders | 20 | 51 | Non-serious | Recovered/Resolved | Unknown | Not applicable | Not applicable | Albuterol; Hydrochlorothiazide; Ibuprofen | Hypothyroidism; Heart failure | Physician | Spontaneous | Possible | 31 | 30 | 0.4 | 1.3 | null |
593CCA96BA6C46F5 | 2023-08-19 | NLD | 60 | adult | Unknown | null | Oncotreat | Asthma | Topical | 10 | mg | Four times daily | 37 | DRESS syndrome | Hypersensitivity | Hypersensitivity conditions NEC | Allergic conditions | Immune system disorders | 177 | 13 | Other medically important condition | Recovered/Resolved | Dose increased | Not applicable | Not applicable | Amoxicillin; Albuterol | Alcohol use disorder; Chronic kidney disease | Consumer | Spontaneous | Unlikely | 16 | 33 | 1 | 0.7 | 12 |
26093CE7ACCAE7D2 | 2023-07-06 | NLD | 55 | adult | Male | 82.5 | Hepatosan | Bipolar disorder | Ophthalmic | 25 | mg | As needed | 73 | Auditory hallucinations | Suicidal ideation | Depressive disorders | Mental disorders NEC | Psychiatric disorders | 159 | 16 | Non-serious | Recovered/Resolved | Drug withdrawn | Positive | Not applicable | null | Rheumatoid arthritis | Consumer | Literature | Probable/Likely | null | 37 | 1 | null | null |
C0B7FD60ABE1ACFF | 2021-07-29 | FIN | 87 | elderly | Female | 59.1 | Infectoban | Migraine prophylaxis | Topical | 10 | mg | Four times daily | 5 | Right ventricular failure | Arrhythmia | Heart failures NEC | Heart failures | Cardiac disorders | 24 | 3 | Non-serious | Recovered with sequelae | Dose not changed | Not applicable | Not applicable | Aspirin | Previous stroke; Benign prostatic hyperplasia | Pharmacist | Spontaneous | Possible | 32 | 13 | null | 1.2 | 11 |
27D3BDF733D6D5B8 | 2025-09-30 | NZL | 80 | elderly | Male | null | Psychostabil | Hypertension | Subcutaneous | 2 | mg | Twice daily | null | Cardiac arrest | Cardiac failure acute | Heart failures NEC | Heart failures | Cardiac disorders | 6 | 16 | Non-serious | Recovering/Resolving | Drug withdrawn | Not applicable | Not applicable | Hydrochlorothiazide | Previous myocardial infarction; Diabetes mellitus type 2 | Physician | Spontaneous | Possible | null | 13 | 0.5 | null | 18 |
B00D32B56922FBCF | 2022-10-09 | FRA | 42 | adult | Unknown | null | Oncotreat | Pain management | Intravenous | 500 | mg | Twice daily | null | Contact dermatitis | Toxic epidermal necrolysis | Rashes, eruptions and exanthems NEC | Epidermal and dermal conditions | Skin and subcutaneous tissue disorders | 164 | null | Non-serious | Recovered/Resolved | Drug withdrawn | Positive | Not applicable | Simvastatin; Levothyroxine | Hypertension | Physician | Literature | Possible | null | 12 | 0.2 | 1.2 | 14 |
F3B5517E735AFF5E | 2023-12-05 | FRA | 61 | adult | Male | 79.8 | Sleepwell | Type 2 diabetes | Oral | 20 | mg | Twice daily | 337 | Decreased WBC | Anemia | Neutropenias | White blood cell disorders | Blood and lymphatic system disorders | 99 | 12 | Non-serious | Recovered/Resolved | Drug withdrawn | Positive | Not applicable | Azithromycin; Simvastatin | Previous stroke; Hepatitis B | Pharmacist | Spontaneous | Possible | 13 | null | 0.6 | 1.2 | 9 |
7B7475EC570AEF49 | 2024-02-07 | RUS | 81 | elderly | Female | 57.9 | Hepatosan | Hyperlipidemia | Transdermal | 5 | mg | null | 722 | Cerebrovascular accident | Hypertension | Hypertension | Vascular hypertensive disorders | Vascular disorders | 24 | null | Non-serious | Recovered/Resolved | Unknown | Not applicable | Not applicable | Clopidogrel; Azithromycin | Coronary artery disease; Rheumatoid arthritis | Pharmacist | Spontaneous | Possible | null | 36 | null | null | 20 |
AB29505FFE1ED1A8 | 2025-07-30 | MEX | 49 | adult | Female | 88.5 | Pulmofix | Hyperlipidemia | Rectal | 10 | mg | As needed | 459 | Mixed hepatic injury | Hepatitis acute | Liver failures and associated disorders | Liver disorders | Hepatobiliary disorders | 145 | null | Disability | Not recovered/Not resolved | Drug withdrawn | Positive | Positive | Acetaminophen; Ibuprofen | Chronic pain | Consumer | Spontaneous | Certain | 787 | 439 | null | 0.9 | 16 |
DF79D294304A19A0 | 2025-06-16 | SWE | 1 | neonate | Female | 43.2 | Anticoag-XR | Osteoarthritis | Intravenous | 50 | mg | Twice daily | null | Oliguria | Acute kidney injury | Acute renal failures | Renal failures and impairments | Renal and urinary disorders | 135 | 14 | Life-threatening | Recovered/Resolved | Unknown | Not applicable | Not applicable | Losartan | Asthma; Peripheral vascular disease; Depression | Physician | Clinical trial | Unlikely | 12 | 36 | 0.2 | 4.5 | null |
9E688451BE8B18B8 | 2023-07-04 | CHE | 49 | adult | Male | 98.4 | Neurobalance | Pain management | Topical | 25 | mg | As needed | 330 | Arthritis pain | Muscle weakness | Myopathies | Muscle disorders | Musculoskeletal and connective tissue disorders | 138 | 78 | Non-serious | Not recovered/Not resolved | Drug withdrawn | Unknown | Not applicable | Losartan; Omeprazole; Prednisone | Hepatitis B; Benign prostatic hyperplasia | Consumer | Spontaneous | Unlikely | 45 | 32 | null | 0.7 | 17 |
13D042D55DAC3022 | 2022-02-06 | NLD | 36 | adult | Unknown | 103.3 | Lipidlow | Seizure disorder | Topical | 25 | mg | Three times daily | 433 | Acute heart failure | Cardiac failure acute | Heart failures NEC | Heart failures | Cardiac disorders | 1 | 49 | Other medically important condition | Recovered/Resolved | Drug withdrawn | Not applicable | Not applicable | Amoxicillin; Furosemide; Omeprazole | Peripheral vascular disease; Occupational chemical exposure; Hypothyroidism | Pharmacist | Clinical trial | Possible | 12 | null | 1.1 | 1.2 | 15 |
8E265E7053ED510E | 2025-08-30 | USA | 44 | adult | Male | 117.6 | Eyeprotect | Asthma | Subcutaneous | 25 | mg | Four times daily | 231 | New malignancy | Carcinoma | Leukaemias NEC | Malignant neoplasms | Neoplasms benign, malignant and unspecified | 125 | 76 | Non-serious | Recovering/Resolving | Dose not changed | Not applicable | Not applicable | Insulin; Losartan; Amlodipine | Hyperlipidemia; Chronic kidney disease; Benign prostatic hyperplasia; Chronic pain | Physician | Spontaneous | Unlikely | 37 | null | 0.7 | 0.8 | null |
59701888752D54BD | 2022-10-01 | IND | 56 | adult | Unknown | null | Anticoag-XR | GERD | Intramuscular | 25 | mg | Once daily | 518 | Skin rash | Toxic epidermal necrolysis | Rashes, eruptions and exanthems NEC | Epidermal and dermal conditions | Skin and subcutaneous tissue disorders | 18 | 52 | Life-threatening | Recovered with sequelae | Dose not changed | Not applicable | Not applicable | Insulin | Occupational radiation exposure | Consumer | Spontaneous | Possible | 45 | null | 0.8 | 1.2 | null |
Synthetic FAERS-Style Pharmacovigilance Dataset (1M Records)
Dataset Description
This is a fully synthetic dataset designed for pharmacovigilance signal detection and ML model training. Contains 1,000,000 synthetic Individual Case Safety Reports (ICSRs).
Features
- 100% Synthetic: No real patient data - GDPR/HIPAA compliant
- 1M Records: Large-scale dataset for ML training
- 35 Features: Causality, temporal, lab values, demographics
- 700+ Drug-Event Signals: Realistic signal patterns
Files
synthetic_faers_1m_pv_signal_ml.csv- PV Signal ML compatible (recommended)synthetic_faers_1m_v2.csv- Original column names
Quick Start
from datasets import load_dataset
Load the dataset dataset = load_dataset("koreo/synthetic-faers-1m-v2", data_files="synthetic_faers_1m_pv_signal_ml.csv", split="train")
Convert to pandas df = dataset.to_pandas() print(f"Loaded {len(df):,} records")
Schema
Drug Information:
- drug_name, dose, route, therapy_duration
Event Information (MedDRA):
- llt, pt, hlt, hlgt, soc
Causality Features:
- dechallenge, rechallenge, causality, action_drug
Temporal:
- ttp_days (time to onset), event_duration
Demographics:
- age, sex, weight, country
Lab Values:
- alt, ast, bilirubin, creatinine, bun
Other:
- concomitant_drugs, medical_history, serious, outcome
Privacy
✅ GDPR Compliant
✅ HIPAA Compliant
✅ 100% Synthetic
✅ No PII/PHI
License
CC0-1.0 (Public Domain)
- Downloads last month
- 8